Literature DB >> 4384520

Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

J R Collins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4384520     DOI: 10.1097/00007611-196804000-00005

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


× No keyword cloud information.
  17 in total

1.  Megaloblastic anaemia associated with sulphasalazine treatment.

Authors:  R E Schneider; L Beeley
Journal:  Br Med J       Date:  1977-06-25

Review 2.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

3.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

4.  Peripheral neuropathy and mesalazine.

Authors:  D K Woodward
Journal:  BMJ       Date:  1989-11-11

Review 5.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

6.  Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.

Authors:  M Farr; E Tunn; P A Bacon; D H Smith
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

7.  Agranulocytosis associated with sulphasalazine therapy.

Authors:  P Cochrane; P Atkins; S Ehsanullah
Journal:  Postgrad Med J       Date:  1973-09       Impact factor: 2.401

8.  Azulfidine- (sulfasalazine-) induced hepatic injury.

Authors:  R S Kanner; F J Tedesco; M H Kalser
Journal:  Am J Dig Dis       Date:  1978-10

9.  Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.

Authors:  H Schröder; D A Evans
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

10.  Systemic granulomatous reaction to salicylazosulfapyridine (Azulfidine) in a patient with Crohn's disease.

Authors:  R J Rafoth
Journal:  Am J Dig Dis       Date:  1974-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.